The development of convergent technologies is at the heart of what the BIOMEDevice exposition and conference is all about. The only European event to focus on next-generation drug-device combination products returns to the Grande Halle de la Villette in Paris this week. Along with a number of companies exhibiting products and services related to this burgeoning field, show organiser UBM Canon, which also produces this blog, has brought together an impressive cohort of industry experts to discuss regulatory and technological developments in this sector. Surgeon Edouard Pélissier, a fellow of the American College of Surgeons and member of the National Academy of Surgery of France and New York Academy of Sciences, will be among the esteemed participants. He will present a paper on 24 February about a bioresorbable product developed by Statice Santé that provides the controlled release of local anaesthetics to minimise postoperative pain.
The technology combines a bioresorbable substrate with local anaesthetics. “The controlled-release implant is placed in the wound by the surgeon to minimise postoperative pain,” explains Pélissier. “Resorption of the substrate and release of bupivacaine have been proven in vitro and in vivo.” The release rate can be modified, and the product can be used on its own, under the form of an analgesic implant that can be placed in any type of surgical wound, or it can be applied on different sorts of medical implantable devices.
“This product will have a significant impact on healthcare by alleviating postsurgical pain,” says Pélissier. “Pain management is crucial for reducing time spent in the hospital. It enables day surgery and, therefore, reduces the cost of healthcare.”
One more example of the fortunate conjunction of medical technology and health economics.
Also contributing to this paper are Christine Millot, an engineer specialised in the characterisation of materials and biomaterials; Claude Roques-Carmes, a professor of materials and biomaterials physics and founder of the Laboratory of Microanalysis of Surfaces at the École Nationale Supérieure de Mécanique et des Microtechniques; and Serge Piranda, an engineer specialised in microtechnology and founder of Statice Santé.
Co-located with Pharmapack, BIOMEDevice will be held 23 and 24 February 2011 at the Grande Halle de la Villette in Paris. Stay tuned to medtechinsider for event coverage throughout the week. The complete BIOMEDEVICE conference schedule is posted on the BIOMEDevice website.Norbert Sparrow